Yahoo Finance·2026-01-08 14:15Group 1: Novo Nordisk - Novo Nordisk's shares fell 41% in 2025 due to leadership changes and reduced guidance, but there is optimism for recovery in the near future [3][5] - The company launched a GLP-1 oral pill for obesity, which is easier to take and cheaper to produce than its injectable counterpart, Wegovy [4] - The stock trades at approximately $55 with a forward P/E ratio of 14, significantly lower than the S&P 500 average of 22, and offers a dividend yield of 3.3% [6] Group 2: Comcast - Comcast's stock is trading around $28 per share with a forward P/E ratio of 7, indicating it is undervalued, and it provides a high dividend yield of 4.5% [7] - The company recently spun off Versant to focus on its core growth areas, including streaming, theme parks, broadband, and wireless, which may enhance its growth prospects [8]